Authors
Latest:
We Need to Act Earlier to Address the Silent Crisis of Kidney Disease, Inadequate Federal SupportThe author discusses a program to prevent kidney decline and progression to dialysis by offering education, support services, and help navigating the health care system to those most at risk.
Latest:
Managed Care COVID-19 Outcomes in a Population Health ProgramData from 38,193 patients showed that managed care patients have COVID-19 risk factors similar to those of the general population and that a population health program decreased mortality.
Latest:
Growth of Electronic Consultations in the Veterans Health AdministrationThis study evaluates the growth in electronic consultation use over the first 7 years after its implementation across the entire Veterans Health Administration system.
Latest:
Impact of Co-pay Assistance on Patient, Clinical, and Economic OutcomesLimited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting improvements in clinical outcomes.
Latest:
Community Health Workers’ Critical Role in Trust Building Between the Medical System and Communities of ColorThe authors interrogate elements of routine medical practice in New York City to argue for reforms of hospital culture through relational trust-building capabilities of community health workers.
Latest:
Cost Savings Associated With a Web-Based Physical Activity Intervention for COPDThe authors modeled costs associated with a pedometer-based, web-mediated physical activity intervention compared with a pedometer alone for chronic obstructive pulmonary disease (COPD) management. The intervention was cost-saving.
Latest:
A Data-Based Foundation for Managing Hypertension ServicesAnalysis of more than 16 million visits for hypertension care suggests that a large fraction of face-to-face care is low value and could be provided differently or potentially eliminated.
Latest:
Medicare Coverage of Buprenorphine-Naloxone Film Surrounding Generic EntryMedicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder.
Latest:
Geographic Variability of Medicaid Acceptance Among Allergists in the USThe proportion of allergists accepting Medicaid in the US varied significantly among and within states.
Latest:
Using a Brief Tool to Assess Healthy School Environments: A Pilot StudyThe authors evaluated a brief assessment tool that accountable care organizations can use to help elementary schools improve student nutrition and increase physical activity.
Latest:
Patients’ Access to 2018 FDA-Approved Drugs 1 Year Post Approval2018 was a landmark year for new drug approvals. However, patients’ access to these novel drugs varied by drug category and enrolled health plan.
Latest:
A Novel Approach to Attribute Responsible Physicians Using Inpatient ClaimsThe authors propose a novel approach in which physicians’ responsibility for inpatient stays is expressed through physician-specific attribution ratios informed by patient characteristics.
Latest:
Social Determinants of Health and High-Cost Utilization Among Commercially Insured PopulationResidence in a more disadvantaged neighborhood was associated with higher likelihood of being a high-cost utilizer among older adults and lower likelihood among younger adults.
Latest:
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency CareCare delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Latest:
Challenges With Implementing the Diabetes Prevention Program for Medicare Beneficiaries in an Integrated Health SystemThis study presents challenges of implementing the CDC-approved Diabetes Prevention Program for Medicare beneficiaries at a large, integrated health care delivery system.
Latest:
Utilization of Low- and High-Value Health Care by Individuals With and Without Cognitive ImpairmentLow-value service utilization is common among all older adults, and utilization of some high-value services decreases after the onset of cognitive decline.
Latest:
Physician Preferences for an Electronic Lung Cancer Screening Decision AidThis qualitative study on primary care physicians yielded suggestions that can inform the design of an effective lung cancer screening decision aid tool and implementation into the electronic health record.
Latest:
Doctors Hate Deductibles: Physicians Pay Thousands to Avoid High DeductiblesNinety percent of physicians did not select a high-deductible health plan although it would save them $1500 to $4000 per year regardless of health spending.
Latest:
Real-world HIV Diagnostic Testing Patterns in the United StatesThis retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory.
Latest:
Study Finds Lp(a), Oxidized Phospholipids Predict Heart Failure ProgressionNew research reveals that elevated lipoprotein(a) and oxidized phospholipids are independent risk factors for early-stage heart failure progression.
Latest:
Elraglusib Granted FDA Orphan Drug Status in Soft Tissue SarcomaThe FDA granted orphan drug designation for elraglusib, a novel drug for treating advanced soft tissue sarcoma.
Latest:
Treatment Modification After Initiating Second-Line Medication for Type 2 DiabetesAmong adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
Latest:
Agreement Among Measures Examining Low-Value Imaging for Low Back PainThis study demonstrates the need for additional consensus surrounding how to translate guideline recommendations to administrative measures assessing imaging overuse for acute low back pain.
Latest:
Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment CostsThe authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.
Latest:
Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care ModelSpending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.
